Thomas C. Shea, MD
UNC Lineberger Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Thomas C. Shea, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:29 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT00963274 · Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaVirginia Commonwealth University · completed · Leukemia, Lymphoma · principal investigator
- Ph1NCT00577694 · Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaUNC Lineberger Comprehensive Cancer Center · terminated · Leukemia · principal investigator
- N/ANCT00489216 · Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous SteroidsUNC Lineberger Comprehensive Cancer Center · terminated · Graft Versus Host Disease · principal investigator
- Ph2NCT00448201 · Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseUNC Lineberger Comprehensive Cancer Center · completed · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma · principal investigator
- Ph1/Ph2NCT00448357 · Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenUNC Lineberger Comprehensive Cancer Center · completed · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma · principal investigator
- Ph1NCT00334438 · Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's LymphomaUNC Lineberger Comprehensive Cancer Center · completed · Lymphoma · principal investigator
- Ph2NCT00003392 · High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast CancerUNC Lineberger Comprehensive Cancer Center · completed · Breast Cancer · study chair
- Ph2NCT00062114 · Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's LymphomaAlliance for Clinical Trials in Oncology · completed · Lymphoma · study chair
- Ph3NCT00004031 · SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaSWOG Cancer Research Network · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Community Outreach and EngagementP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Kim Felder Rhoads · fiscal years 2018 to 2026Named on NCT00963274
- R21CA137823RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00963274
- Clinical Research ProgramP30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Matthew I Milowsky · fiscal years 2018 to 2026
- U10CA032102RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00004031
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.